MAPT and Alzheimer disease: GSK-3β was the first identified tau kinase, which can phosphorylate tau at most of the hyperphosphorylated sites seen in the PHFs isolated from AD brains (Lovestone et al., 1994; Hong et al., 1997; Lucas et al., 2001; Hernandez et al., 2013).